Syringocystadenoma Papilliferum of The External Auditory Canal: Case Report and Literature Review.
SCAP of the EAC - Case Reports
Juliana Cristina Mesti, Inaê Mattoso Compagnoni, Trissia Maria Farah Vassoler, Gilberto da Fontoura Rey Bergonse, Mariana Nagata Cavalheiro, Bruno Amaral Hay, Rafaela Mabile Ferreira dos Santos Sobreiro*, Rodrigo Marques Borburema and Rodrigo Alvarez Cardoso
Hospital Cruz Vermelha, Paraná, Brasil
Submission: July 02, 2018; Published: July 13, 2018
*Corresponding author: Rafaela Mabile Ferreira dos Santos Sobreiro,Rua Visconde do Rio Branco, 1102,MercêsCuritiba, Paraná, Brasil,
Tel: 5541999572835; Email: firstname.lastname@example.org
How to cite this article: Juliana, Inaê Mattoso, Trissia Maria Farah, Gilberto, Mariana Nagata, et al. SyringocystadenomaPapilliferumofThe External Auditory
Canal: Case Report and Literature Review.SCAP of the EAC - Case Report. Glob J Oto, 2018; 16(3): 555940. DOI: 10.19080/GJO.2018.16.555940
CAAconsulted with a hypoacusis tinnitus and atrial fullness on the left ear.CT of the ears and histopathological whose diagnosis was SCAP.SCAP is a benign neoplasm rare in EAC, but because it is a benign tumor with potential for malignancy,suspicion of diagnosis is important.
Syringocystadenomapapilliferum (SCAP) is an uncommon benign adnexal neoplasm [1,2],which is frequently located on the scalp, with extremely rare appearance in the external auditory canal (CAE) [3,4].Its origin is still uncertain, but it is believed to be apocrine , Syringocystadenomapapilliferum is mostly associated with other benign neoplasms, where sebaceous nevus is involved in 40% of the cases [3,5].The clinical signs vary from asymptomatic patients to hearing loss and the diagnosis is based on histopathological evaluation .
A 49-year-old female patient was seen in the otorhinolaryngology department due to hearing loss, tinnitus and left atrial fullness which have begun 6 months ago. She reported improvement in symptoms as she pressed the lobe from the left ear downwards. She had no previous history of otitis, or otological traumas. Physical examination revealed a bulging of the upper region of the left external auditory canal causing its total obstruction, and it was not possible to visualize the tympanic membrane and without local cutaneous alterations. Audiometry showed moderate to severe conductive hearing loss on the left and audiometry with left b-curve. A computed tomography scan of the ears was performed showing well-developed mastoid,
with no soft tissue material, with left ear canal stenosis.The patient was submitted to a surgery in order to excise the lesion and the material was sent for anatomopathological study, which
resulted in syringocystadenomapapilliferum of the external auditory canal and absence of malignancy. Patient remains on outpatient follow-up.
Syringocystadenomapapilliferum EAC was first described in 1971 by John Stokes and it is an uncommon benign neoplasm whose origin is still uncertain.In about 50% of cases, SCAP is present at birth and in 15% it appears until infancy .Therefore, it appears to be a tumor originated from undifferentiated cells with differentiation potential for eccrine cells or, more commonly, apocrine cells [4,5,8].Other studies also point to the possibility of involvement of human papillomavirus (HPV) in the genesis of this tumor .In 2004, Thompson et al updated the WHO (1991) and Wetli (1972) classifications and divided the lesions into: benign, which includes cerumen, pleomorphic and papillary adenomas and malignant adenomas (adenocarcinomas). Until 2016, there are only 150 reports in the literature of tumors of ceruminous glands, which only 11 are papillary seringocystadenoma.
When present in the EAC, the clinical manifestations of the tumor vary and depend mainly on its development, once they may show as masses or ulcers. Initially, it is an asymptomatic disease, however, due to its growth, it can evolve to a sense of atrial fullness, cerumen impaction, external otitis and conductive hearing loss. Although there is rarely malignant transformation, there are already cases described in the
literature of papillary syringocystadenocarcinoma.The
diagnosis is given by the histopathological evaluation of the
tumor, observing «cup» epithelial lesions frequently cavitated
and covered by a layer of hyperkeratosis and acanthosis that
invaginate and form the papillae. Imaging examinations, such as
computed tomography and magnetic resonance imaging, may be
useful to assess the extension, aiding in preoperative evaluation
.There is no recommended treatment yet, however, it is
suggested that the excision of the lesion be performed with or
without graft and follow-up indefinitely.
SCAP is a rare benign tumor of uncertain origin with better
therapeutic care and follow-up yet to be defined. Because there
is a potential for malignancy, it is of the utmost importance that
studies be performed to establish the conducts to be taken in
case of this tumor.